Literature DB >> 1825103

The fate of CD4-8- T cell receptor-alpha beta+ thymocytes.

H I Levitsky1, P T Golumbek, D M Pardoll.   

Abstract

CD4-8- TCR-alpha beta+ thymocytes represent a distinct population whose fate and function have remained a mystery. We show here that this thymocyte subset bears NK1, a surface Ag previously thought to be expressed exclusively by TCR- NK cells. Analysis of peripheral lymphocytes for the coexpression of TCR-alpha beta and NK1 revealed a subset with similar characteristics to the NK1+ thymocytes: a large fraction that are CD4-8- and a skewed TCR repertoire in which V beta 8 is overrepresented. Thymus transplant experiments into congenically marked athymic (nude) mice revealed that the NK1+TCR alpha beta+ subset was exclusively thymus derived and represented a distinct subset from the thymus-independent NK1+TCR- population. Finally, the NK1+TCR alpha beta+ population preferentially localizes to the bone marrow. These results demonstrate that this T cell subset is exported to the periphery after developing in the thymus. Their unique surface Ag expression and tissue localization suggest an immune function distinct from classical T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825103

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Lymphoid precursor cell lines have capacity to migrate to multiple lymphoid sites.

Authors:  H C O'Neill; K Ni; T J O'Neill
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

2.  Self-reactive forbidden clones are confined to pathways of intermediate T-cell receptor cell differentiation even under immunosuppressive conditions.

Authors:  T Moroda; Y Kawachi; T Iiai; A Tsukahara; S Suzuki; T Tada; H Watanabe; K Hatakeyama; T Abo
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Development of Valpha4+ NK T cells in the early stages of embryogenesis.

Authors:  Y Makino; R Kanno; H Koseki; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.

Authors:  K Tamada; M Harada; O Ito; M Takenoyama; T Mori; G Matsuzaki; K Nomoto
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

5.  Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells.

Authors:  M Nakui; A Ohta; M Sekimoto; M Sato; K Iwakabe; T Yahata; H Kitamura; T Koda; T Kawano; H Makuuchi; M Taniguchi; T Nishimura
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

6.  Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; H Sato; E Kondo; M Harada; H Koseki; T Nakayama; Y Tanaka; M Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

10.  Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.

Authors:  M Taniguchi; H Koseki; T Tokuhisa; K Masuda; H Sato; E Kondo; T Kawano; J Cui; A Perkes; S Koyasu; Y Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.